Generation of fully human anti-TNF antibody D2E7

被引：0
|
作者：
Salfield, J
Kaymakçalan, J
Tracey, D
Roberts, A
Kamen, R
机构：
[1] BASF Biores Corp, Worcester, MA USA
[2] Cambridge Antibody Technol Grp Plc, Melbourn, England
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Efficacy of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.
    van de Putte, BA
    Rau, R
    Breedveld, FC
    Kalden, JR
    Malaise, MG
    Schattenkirchner, M
    Emery, P
    Burmester, GR
    Zeidler, H
    Moutsopoulos, HH
    Compagnone, D
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S400 - S400
  • [2] Preliminary results of early clinical trials with the fully human anti-TNFα monoclonal antibody D2E7
    Kempeni, J
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 70 - 72
  • [3] One year efficacy results of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.
    van de Putte, LBA
    Rau, R
    Breedveld, FC
    Kalden, JR
    Malaise, MG
    Schattenkirchner, M
    Emery, P
    Burmester, GR
    Zeidler, H
    Dressler, R
    Compagnone, D
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S269 - S269
  • [4] Long-term use of the fully human anti-TNF antibody D2E7 in combination with methotrexate in active rheumatoid arthritis.
    Schattenkirchner, M
    Wastlhuber, J
    Rau, R
    Herborn, G
    Kroot, EJ
    van Riel, PLCM
    van de Putte, LBA
    Ailaart, CF
    Breedveld, FC
    Fenner, H
    Theophil, E
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S228 - S228
  • [5] Prevention of polyarthritis in human TNF transgenic mice by D2E7:: A fully human anti-human TNF monoclonal antibody.
    Kaymakçalan, Z
    Haralambous, S
    Tracey, D
    Kamen, R
    Salfeld, J
    Kollias, G
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S97 - S97
  • [6] A single dose placebo controlled phase 1 study of the fully human anti-TNF antibody D2E7 in patients with rheumatoid arthritis.
    van de Putte, LBA
    van Riel, PLCM
    den Broeder, A
    Sander, O
    Rau, R
    Binder, C
    Krüger, K
    Schattenkircher, M
    Fenner, H
    Salfeld, J
    Bankmann, Y
    Kupper, H
    Kempeni, J
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S57 - S57
  • [7] Improvement in health utility among rheumatoid arthritis (RA) patients treated with adalimumab (D2E7),a fully human anti-TNF monoclonal antibody
    van de Putte, L
    Boggs, R
    Sengupta, N
    Dietz, B
    Bergemann, R
    Rosery, H
    Kupper, H
    VALUE IN HEALTH, 2002, 5 (06) : 461 - 461
  • [8] The effect of D2E7, a new human anti-TNFα monoclonal antibody, on the oxidative burst of PMN in patients with RA.
    den Broeder, AA
    Wanten, GJA
    van Riel, PLCM
    Kroot, EJ
    Naber, THJ
    Barrera, P
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S57 - S57
  • [9] Pharmacokinetics of the fully human anti-TNF-α monoclonal antibody adalimumab (D2E7) in the non-human primate.
    Bankmann, Y
    Buehler, V
    Kaymakçalan, Z
    Lassmann, A
    Salfeld, J
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S72 - S72
  • [10] Update on D2E7:: a fully human anti-tumour necrosis factor α monoclonal antibody
    Kempeni, J
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 : 44 - 45
12345